Хронічне обструктивне захворювання легень: гетерогенність перебігу (огляд літератури)

T. M. Khrystych; A. I. Fediv; A. A. Iliushyna; Ya. M. Teleki; O. Yu. Oliinyk

doi:10.24061/217967

Автор(и)

T. M. Khrystych
A. I. Fediv
A. A. Iliushyna
Ya. M. Teleki
O. Yu. Oliinyk

DOI:

https://doi.org/10.24061/217967

Ключові слова:

хронічне обструктивне захворювання легень, фенотипи, кардіоваскулярні порушення

Анотація

Проведено огляд літератури з особливостей фенотипування хронічного обструктивного захворювання легень (ХОЗЛ). Відображено динаміку вивчення даної проблеми. Наведено деякі особливості перебігу ХОЗЛ на тлі кардіоваскулярних змін, основні патогенетичні механізми, роль біомаркерів у прогресуванні захворювання.

Посилання

Avramenko LP, Bolotnova TV. Kliniko-funktsional'nye kharakteristiki khronicheskoy obstruktivnoy bolezni legkikh u zhenshchin pozhilogo vozrasta [Clinical and functional characteristics of chronic obstructive pulmonary disease in elderly women]. Klinicheskaya gerontologiya. 2008;9:19. (in Russian).

Babynets' LS, Kvasnits'ka OS. Rol' pro- ta antyoksydantnoho statusu i tiutiunopalinnia u formuvanni trofolohichnykh rozladiv pry khronichnomu pankreatyti u poiednanni z khronichnym obstruktyvnym zakhvoriuvanniam lehen' [The role of pro- and antioxidant status and smoking in the formation of trophological disorders in chronic pancreatitis in combination with chronic obstructive pulmonary disease]. Novosti meditsiny i farmatsii. 2011;382:73-5. (in Ukrainian).

Krakhmalova OO, Voieikova LS, Talalai IV. Systemne zapalennia yak faktor rozvytku pozalehenevykh uskladnen' KhOZL [Systemic inflammation as a factor in the development of extrapulmonary complications of COPD]. Ukrains'kyi terapevtychnyi zhurnal. 2011;2:79-83. (in Ukrainian).

Mostovoy YuM. Vybor antibakterial'nogo preparata pri obostrenii KhOZL v ambulatornykh usloviyakh na osnovanii farmakoekonomicheskogo analiza [The choice of an antibacterial drug for exacerbation of COPD on an outpatient basis based on pharmacoeconomic analysis]. Ukrains'kyi pul'monolohichnyi zhurnal. 2011;2:18-20. (in Russian).

Nevzorova VA, Tilik TV, Gilifanov EA, Vakhrusheva SE, Panchenko EA, Kudryavtseva VA, et al. Soderzhanie svobodnoy metalloproteinazy MMR9 i kompleksa MMR9/TІMR1 v syvortoke krovi pri stabil'nom techenii khronicheskoy obstruktivnoy bolezni legkikh, assotsiirovannoy s ishemicheskoy bolezn'yu serdtsa [The content of free metalloproteinase MMP9 and the complex MMP9 / TMP1 in the blood serum with a stable course of chronic obstructive pulmonary disease associated with coronary heart disease]. Pul'monologiya. 2011;2:75-80. (in Russian).

Ovcharenko SI. Fenotipy bol'nykh khronicheskoy obstruktivnoy bolezn'yu legkikh i issledovanie ECLIPSE: pervye rezul'taty [Phenotypes of patients with chronic obstructive pulmonary disease and the ECLIPSE study: first results]. Pul'monologiya. 2011;3:113-7. (in Russian).

Pertseva TA. Myshechnaya disfunktsiya pri KhOBL: pereotsenka problemy, novye vozmozhnosti terapii [Muscular dysfunction in COPD: reassessment of the problem, new treatment options]. Ukrains'kyi pul'monolohichnyi zhurnal. 2008;3-1:17-9. (in Russian).

Teleki YaM. Riven' hliukozy, insulinu, S-peptydu u khvorykh na khronichne obstruktyvne zakhvoriuvannia lehen' u poiednanni z khronichnym pankreatytom [The level of glucose, insulin, C-peptide in patients with chronic obstructive pulmonary disease in combination with chronic pancreatitis]. Praktychna medytsyna. 2008;14(3):165-9. (in Ukrainian).

Todoriko LD. Dyferentsiiovane zastosuvannia bronkholitykiv u likuvanni khronichnykh obstruktyvnykh zakhvoriuvan' leheniv u osib starshykh vikovykh hrup [Differentiated use of bronchodilators in the treatment of chronic obstructive pulmonary disease in the elderly]. Klinicheskaya immunologiya. Allergologiya. Infektologiya. 2011;3:83-6. (in Ukrainian).

Todoriko LD. Osoblyvosti prohresuvannia systemnoho zapalennia pry khronichnykh obstruktyvnykh zakhvoriuvanniakh leheniv patsiientiv pokhyloho ta starechoho viku [Features of the progression of systemic inflammation in chronic obstructive pulmonary disease in elderly and senile patients]. Klinicheskaya immunologiya. Allergologiya. Infektologiya. 2010;3:58-62. (in Ukrainian).

Todoriko LD. Patohenetychna kharakterystyka prohresuvannia systemnoho zapalennia pry khronichnykh obstruktyvnykh zakhvoriuvanniakh lehen' u litn'omu ta starechomu vitsi [Pathogenetic characteristics of the progression of systemic inflammation in chronic obstructive pulmonary diseases in the elderly and elderly]. Ukrains'kyi terapevtychnyi zhurnal. 2010;2:107-12. (in Ukrainian).

Feshchenko YuI. Aktual'nye voprosy khronicheskogo obstruktivnogo zabolevaniya legkikh [Actual issues of chronic obstructive pulmonary disease]. Ukrains'kyi pul'monolohichnyi zhurnal. 2010;1:5-8. (in Russian).

Feschenko YuI, Cheren'ko SO. Khronichne obstruktyvne zakhvoriuvannia lehen' i tuberkul'oz: patohenetychnyi zv’iazok i problemy likuvannia poiednanoho zakhvoriuvannia [Chronic obstructive pulmonary disease and tuberculosis: pathogenetic communication and problems in the treatment of comorbid disease]. Zdorov’ia Ukrainy. Pul'monolohiia, alerholohiia, otorynolarynholohiia (tematychnyi nomer). 2011;4:30-1. (in Ukrainian).

Khristich TN. Khronicheskoe legochnoe serdtse: sovremennye kontseptsii [Chronic pulmonary heart: modern concepts]. Chernivtsi. Knigi XXI; 2009. 368 р. (in Russian).

Yashina LA. Obosnovanie tselesoobraznosti i analiz effektivnosti kombinirovannoy terapii khronicheskogo obstruktivnogo zabolevaniya legkikh [Justification of the feasibility and analysis of the effectiveness of combination therapy of chronic obstructive pulmonary disease]. Astma ta alerhiia. 2011;2:37-41. (in Russian).

Agusti A, Calverely P, Celli B, Coxson HO, Edwards LD, Lomas DA, et al. Celli Characterization of COPD heterogeneity in the ECLIPSE cohort. Respire Res. 2010;11:122.

Behar S, Panosh A, Reicher-Reiss H, Zion M, Schlesinger Z, Goldbourt U. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infection SPRINT Study Group. Am J Med. 1992;93(6):637-41.

Casanova C, Cote C, de Torres J, Aguirre-Jaime A, Marin JM, Pinto-Plata V, et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005;171(6):591-7.

Curkendall S, Lanes S, de Luise C, Stang MR, Jones JK, She D, et al. Chronic obstructive pulmonary disease severity and cardiovascular outcomes. Eur. J. Epidemiol. 2006;21(11):802-13.

Danker R, Goldbourt U, Boyko V, Reicher-Reiss H. Predictors of cardiac and noncardiac mortality among 14,697 patients with coronary heart disease. Amer. J. Cardiol. 2003;91(2):121-7.

Donaldson GC, Wilkinson TM, Hurst JR, Perera WR, Wedzicha JA. Exacerbation and time spent outdoors in chronic obstructive pulmonary disease. Am. J. Respire. Crit. Care Med. 2005;171(5):446-52.

Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO workshop report. Last updated 2009. Available from: www.goldcopd.org.

Hurst J, Vestbo J, Anzueto A, Locantore N, Müllerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363(12):1128-38.

Jensen H, Godtfredsen N, Lange P, Vestbo J. Potential misclassification of causes of death from COPD. Eur Respir J. 2006;28(4):781-5.

Jones PW, Agusti AG. Ourcomes and markers of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(4):822-32.

Kanner RE, Anthonisen NR, Connet JE. Lower respiratory illnesses promote FEV1 decline in current smokers but not ex- smokers with mild chronic obstructive pulmonary disease. Am J Respire Crit Care Med. 2001;164(3):358-64.

Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434-40.

Rabe K, Hurd S, Anzueyo A. Global Initiative for Chronic Obstructive Lung Disease Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respire Crit Care Med. 2007;176(6):532-55.

Radom S, Kaminski N, Hayek S, Halkin H, Cooper DM, Ben-Dov I. Effects of exercise training on quadriceps muscle gene expression in chronic obstructive pulmonary disease. J Appl Physiol. 2007;102(10):1976-9184.

Schols A, Slangen J, Volovics L, Wouters EF. Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1791-6.

Solomon AM, Bouloux PM. Modifying musclemass – the endocrine perspective. J Endocrinol. 2006;191(2):349-60.

Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, et al. Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J. 2008;31(4):869-73.

Wagner PD. Possible mechanisms underlying the development of cachexia in COPD. Eur Respir J. 2008;31(3):492-501.